Bruker
Bruker is a Private Indian company incorporated in 1960 and based in Maharashtra, India. Bruker operates in Medical & Precision (NIC 33125) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Bruker - Manufacturer of high-performance scientific instruments for life sciences. Public Company. Raised funding over 40 rounds from 7 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Bruker.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +36d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Bruker.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 646138611 | ICICI Bank Ltd(Bank) | ₹20.91 Cr | 27 Jan 2023 | Open |
| 226657724 | HDFC Bank Ltd(Bank) | ₹21.91 Cr | 12 Mar 2019 | Open |
| 311664239 | ICICI Bank Ltd(Bank) | ₹11.21 Cr | 27 Jan 2019 | Open |
| 316966580 | State Bank of India(Bank) | ₹22.00 Cr | 27 Jan 2019 | Open |
| 501146125 | ICICI Bank Ltd(Bank) | ₹2.76 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for Bruker.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹33.06 Cr | ₹1.42 Cr | ₹26.56 Cr | ₹55.39 Cr | 203 |
| FY2023-24 | ₹30.06 Cr | ₹1.68 Cr | ₹18.18 Cr | ₹32.68 Cr | 245 |
| FY2022-23 | ₹20.38 Cr | ₹76.37 L | ₹9.43 Cr | ₹25.16 Cr | 163 |
| FY2021-22 | ₹15.97 Cr | ₹38.08 L | ₹11.62 Cr | ₹17.53 Cr | 78 |
Audited financials & ratios for Bruker.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹33.06 Cr | ₹30.06 Cr | ₹20.38 Cr | ₹15.97 Cr |
| Other income | ₹1.08 Cr | ₹1.11 Cr | ₹45.73 L | ₹38.77 L |
| Total income | ₹34.14 Cr | ₹31.17 Cr | ₹20.84 Cr | ₹16.36 Cr |
| Total expenses | ₹32.32 Cr | ₹29.01 Cr | ₹19.86 Cr | ₹15.87 Cr |
| Profit before tax | ₹1.84 Cr | ₹2.19 Cr | ₹99.28 L | ₹49.51 L |
| Profit / (Loss) after tax | ₹1.42 Cr | ₹1.68 Cr | ₹76.37 L | ₹38.08 L |
| Balance sheet | ||||
| Equity / Net worth | ₹26.56 Cr | ₹18.18 Cr | ₹9.43 Cr | ₹11.62 Cr |
| Borrowings | ₹9.92 Cr | ₹6.03 Cr | ₹4.14 Cr | ₹1.84 Cr |
| Current liabilities | ₹15.93 Cr | ₹8.44 Cr | ₹7.08 Cr | ₹3.30 Cr |
| Total liabilities | ₹28.83 Cr | ₹14.50 Cr | ₹15.74 Cr | ₹5.91 Cr |
| Current assets | ₹25.66 Cr | ₹18.18 Cr | ₹14.01 Cr | ₹8.01 Cr |
| Cash & equivalents | ₹3.59 Cr | ₹6.76 Cr | ₹2.00 Cr | ₹2.39 Cr |
| Total assets | ₹55.39 Cr | ₹32.68 Cr | ₹25.16 Cr | ₹17.53 Cr |
| Employees | 203 | 245 | 163 | 78 |
Audited financials & ratios for Bruker.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹33.06 Cr | +8.8% | +11.7% | +6.5% |
| Profit after Tax | ₹1.42 Cr | +8.8% | -0.7% | +13.0% |
| Net Worth | ₹26.56 Cr | -6.8% | +8.2% | +14.3% |
| Employees | 203 | -0.3% | +16.9% | +3.8% |
Audited financials & ratios for Bruker.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹33.06 Cr | ₹1.42 Cr | +4.29% | +17.43% | +5.34% | +2.56% | 0.37 | ₹16.28 L |
| FY2023-24 | ₹30.06 Cr | ₹1.68 Cr | +5.60% | +11.70% | +9.26% | +5.15% | 0.33 | ₹12.27 L |
| FY2022-23 | ₹20.38 Cr | ₹76.37 L | +3.75% | +0.90% | +8.10% | +3.03% | 0.44 | ₹12.50 L |
| FY2021-22 | ₹15.97 Cr | ₹38.08 L | +2.38% | +11.84% | +3.28% | +2.17% | 0.16 | ₹20.48 L |
Audited financials & ratios for Bruker.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,01,01,077 | 64.40% |
| Institutional Investors | 2 | 33,60,595 | 10.77% |
| Public & Others | 49 | 77,50,858 | 24.83% |
Promoter, institutional & public holding for Bruker.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
675 peersEvents & timeline
1External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.